Life Sciences

CDR Life Sciences Team supports Acacia Pharma’s €190 million Initial Global Offering

The CDR Life Sciences team supported Acacia Pharma on its successful €190 million Initial Global Offering (IGO) and listing on Euronext Brussels in March 2018. In raising EUR 40 million, Acacia Pharma’s listing is the largest on Euronext since 2015 and the first Pharma company listing on Euronext Brussels in 2018. 

Future of Healthcare Investor Forum

The Citigate Dewe Rogerson Life Sciences team recently co-sponsored the Future of Healthcare Investor Forum alongside J.P. Morgan and Numis and industry partners BIA and OneNucleus.

Back to basics: content, content and… #relevance

We all know that content is king when devising a communications strategy, especially for a traditional media programme. So why is it any different for social media, or at least on the face of it?

Feel the love: funding for emerging life sciences companies

If you’re an emerging life sciences company you may be feeling rather unloved at the moment, with pharma giant Pfizer and UK champion AstraZeneca being the key focus of media scrutiny.